VYNE Therapeutics Inc. (VYNE)

VYNE Therapeutics Statistics

Total Valuation

VYNE has a market cap or net worth of $20.82 million. The enterprise value is -$8.19 million.

Market Cap	20.82M
Enterprise Value	-8.19M

Important Dates

The next estimated earnings date is Thursday, May 7, 2026, before market open.

Earnings Date	May 7, 2026
Ex-Dividend Date	n/a

Share Statistics

VYNE has 33.04 million shares outstanding. The number of shares has increased by 0.42% in one year.

Current Share Class	33.32M
Shares Outstanding	33.04M
Shares Change (YoY)	+0.42%
Shares Change (QoQ)	+0.08%
Owned by Insiders (%)	2.47%
Owned by Institutions (%)	28.06%
Float	32.50M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	36.52
Forward PS	25.51
PB Ratio	0.76
P/TBV Ratio	0.75
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 12.53

Current Ratio	12.53
Quick Ratio	12.11
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -66.96% and return on invested capital (ROIC) is -46.51%.

Return on Equity (ROE)	-66.96%
Return on Assets (ROA)	-38.31%
Return on Invested Capital (ROIC)	-46.51%
Return on Capital Employed (ROCE)	-107.15%
Weighted Average Cost of Capital (WACC)	15.43%
Revenue Per Employee	$57,000
Profits Per Employee	-$2.65M
Employee Count	10
Asset Turnover	0.01
Inventory Turnover	n/a

Taxes

In the past 12 months, VYNE has paid $4,000 in taxes.

Income Tax	4,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -64.41% in the last 52 weeks. The beta is 2.03, so VYNE's price volatility has been higher than the market average.

Beta (5Y)	2.03
52-Week Price Change	-64.41%
50-Day Moving Average	0.58
200-Day Moving Average	0.59
Relative Strength Index (RSI)	62.30
Average Volume (20 Days)	225,997

Short Selling Information

The latest short interest is 212,702, so 0.64% of the outstanding shares have been sold short.

Short Interest	212,702
Short Previous Month	549,047
Short % of Shares Out	0.64%
Short % of Float	0.65%
Short Ratio (days to cover)	0.47

Income Statement

In the last 12 months, VYNE had revenue of $570,000 and -$26.48 million in losses. Loss per share was -$0.62.

Revenue	570,000
Gross Profit	570,000
Operating Income	-29.75M
Pretax Income	-26.73M
Net Income	-26.48M
EBITDA	-29.73M
EBIT	-29.75M
Loss Per Share	-$0.62

Balance Sheet

The company has $29.01 million in cash and n/a in debt, with a net cash position of $29.01 million or $0.88 per share.

Cash & Cash Equivalents	29.01M
Total Debt	n/a
Net Cash	29.01M
Net Cash Per Share	$0.88
Equity (Book Value)	27.77M
Book Value Per Share	0.83
Working Capital	27.62M

Cash Flow

Operating Cash Flow	-33.12M
Capital Expenditures	n/a
Depreciation & Amortization	23,000
Net Borrowing	n/a
Free Cash Flow	-33.12M
FCF Per Share	-$1.00

Margins

Gross Margin	100.00%
Operating Margin	-5,219.12%
Pretax Margin	-4,689.82%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

VYNE does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.42%
Shareholder Yield	-0.42%
Earnings Yield	-127.22%
FCF Yield	-159.12%

Analyst Forecast

Price Target	n/a
Price Target Difference	n/a
Analyst Consensus	Hold
Analyst Count	1
Revenue Growth Forecast (5Y)	182.19%
EPS Growth Forecast (5Y)	-8.01%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on February 13, 2023. It was a reverse split with a ratio of 1:18.

Last Split Date	Feb 13, 2023
Split Type	Reverse
Split Ratio	1:18

Scores

VYNE has an Altman Z-Score of -32.25 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-32.25
Piotroski F-Score	2